N-benzyl-4-(3-(pyridin-4-ylmethyl)ureido)benzenesulfonamide

ID: ALA4877035

PubChem CID: 68248942

Max Phase: Preclinical

Molecular Formula: C20H20N4O3S

Molecular Weight: 396.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NCc1ccncc1)Nc1ccc(S(=O)(=O)NCc2ccccc2)cc1

Standard InChI:  InChI=1S/C20H20N4O3S/c25-20(22-14-17-10-12-21-13-11-17)24-18-6-8-19(9-7-18)28(26,27)23-15-16-4-2-1-3-5-16/h1-13,23H,14-15H2,(H2,22,24,25)

Standard InChI Key:  WJODKZZQLZOOIT-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 28 30  0  0  0  0  0  0  0  0999 V2000
   17.4885   -9.0767    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3645   -7.9614    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7772   -8.6713    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.1856   -7.9589    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7141  -10.3304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7129  -11.1500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4210  -11.5589    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1306  -11.1495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1278  -10.3268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4192   -9.9216    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8340   -9.9156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5432  -10.3215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.2494   -9.9102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9586  -10.3161    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.6648   -9.9049    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2463   -9.0930    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.3700  -10.3126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0757   -9.9020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0731   -9.0839    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3589   -8.6782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6561   -9.0911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1939   -8.6642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9039   -9.0688    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9045   -9.8858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6136  -10.2904    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3200   -9.8778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.3128   -9.0564    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6031   -8.6555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  3  2  2  0
  4  3  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 13 16  2  0
 15 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 15  1  0
 19  3  1  0
  3  1  1  0
  1 22  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
M  END

Associated Targets(Human)

NAMPT Tchem Nicotinamide phosphoribosyltransferase (3221 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 396.47Molecular Weight (Monoisotopic): 396.1256AlogP: 2.88#Rotatable Bonds: 7
Polar Surface Area: 100.19Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 10.18CX Basic pKa: 5.02CX LogP: 2.16CX LogD: 2.16
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.76

References

1. Pinkerton AB, Sessions EH, Hershberger P, Maloney PR, Peddibhotla S, Hopf M, Sergienko E, Ma CT, Smith LH, Jackson MR, Tanaka J, Tsuji T, Akiu M, Cohen SE, Nakamura T, Gardell SJ..  (2021)  Optimization of a urea-containing series of nicotinamide phosphoribosyltransferase (NAMPT) activators.,  41  [PMID:33798699] [10.1016/j.bmcl.2021.128007]

Source